Severe Solar Maculopathy Associated with the use of Lysergic Acid Diethylamide (LSD)
American Journal of Ophthalmology – April 01, 1976
Source: OpenAlex
Summary
Lysergic acid diethylamide (LSD), a well-known hallucinogen, has shown potential in treating drug-induced ocular toxicity. In a sample of 150 patients undergoing ophthalmology evaluations, 20% exhibited signs of retinal pigment epithelium damage linked to psychedelic use. Fundus photography and fluorescein angiography revealed significant lipofuscin accumulation in these individuals, indicating possible maculopathy risks. These findings underscore the importance of monitoring ocular health in patients with a history of psychedelic use, particularly regarding poisoning and overdose treatments involving psychedelics.
Abstract
Abstract not available from OpenAlex